Results 201 to 210 of about 298,387 (354)
COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos +6 more
wiley +1 more source
Is there still room for pioglitazone in contemporary type 2 diabetes management? [PDF]
Caruso I.
europepmc +1 more source
Packaging Fatwa in the Post Truth Era: MUI Fatwa Contest Facing New Religious Authority
Achmad Muhibin Zuhri +2 more
openalex +2 more sources
23 / EMBELLISHING THE TOKUHASHI SCORE IN THE ERA OF NEWER SYSTEMIC THERAPIES [PDF]
openaire +1 more source
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen +11 more
wiley +1 more source
Optimizing Crohn's Disease Management in the Biologic Era-Insights from Real-World Evidence in Japan. [PDF]
Fukuzawa M.
europepmc +1 more source
Social interventions: a new era for global mental health?
Rochelle A. Burgess +3 more
openalex +2 more sources
Hepatitis C in Pregnancy - Universal Screening in the Era of Newer Antivirals
openaire +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
What are the Real Achievements in Spine Surgery? [PDF]
Chapman JR, Wang JC, Wiechert K.
europepmc +1 more source

